| Erin M Aldag, MD | |
|
81 N Mario Capecchi Dr, Salt Lake City, UT 84113-1125 | |
| (801) 662-5700 | |
| Not Available |
| Full Name | Erin M Aldag |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 81 N Mario Capecchi Dr, Salt Lake City, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518596014 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 12419670-1205 (Utah) | Primary |
| 208000000X | Pediatrics | 12419670-1205 (Utah) | Secondary |
| Entity Name | University Of Utah Pediatric Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487018974 PECOS PAC ID: 0547552473 Enrollment ID: O20160713000371 |
News Archive
"Pressure is mounting on WellPoint Inc. Chief Executive Angela Braly, who faced tough questions about the health insurer's practices at its annual shareholders meeting Tuesday, before the gathering ended abruptly after a director collapsed," The Wall Street Journal reports.
The website Nursing Home Compare, sponsored by the Centers for Medicare & Medicaid Services, is a go-to resource for many families researching nursing home options for their loved ones.
Regular exercise is touted as an antidote for many ills, including stress, depression and obesity. Physical activity also may help decrease violent behavior among adolescent girls, according to new research to be presented Monday, May 6, at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
Medtronic, Inc. today announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug Administration (FDA) approval for the Medtronic Arctic Front® Cardiac CryoAblation Catheter System, which is designed for patients with paroxysmal atrial fibrillation (PAF), an irregular quivering of the upper chambers of the heart that starts and stops on its own. Atrial fibrillation (AF) is the most common heart arrhythmia in the United States, with an estimated three million patients suffering from this condition.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin M Aldag, MD 81 N Mario Capecchi Dr, Salt Lake City, UT 84113-1125 Ph: (801) 662-5700 | Erin M Aldag, MD 81 N Mario Capecchi Dr, Salt Lake City, UT 84113-1125 Ph: (801) 662-5700 |
News Archive
"Pressure is mounting on WellPoint Inc. Chief Executive Angela Braly, who faced tough questions about the health insurer's practices at its annual shareholders meeting Tuesday, before the gathering ended abruptly after a director collapsed," The Wall Street Journal reports.
The website Nursing Home Compare, sponsored by the Centers for Medicare & Medicaid Services, is a go-to resource for many families researching nursing home options for their loved ones.
Regular exercise is touted as an antidote for many ills, including stress, depression and obesity. Physical activity also may help decrease violent behavior among adolescent girls, according to new research to be presented Monday, May 6, at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
Medtronic, Inc. today announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug Administration (FDA) approval for the Medtronic Arctic Front® Cardiac CryoAblation Catheter System, which is designed for patients with paroxysmal atrial fibrillation (PAF), an irregular quivering of the upper chambers of the heart that starts and stops on its own. Atrial fibrillation (AF) is the most common heart arrhythmia in the United States, with an estimated three million patients suffering from this condition.
› Verified 2 days ago
Jeffrey Von Miller, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8 Th Ave And C St, Intermountain Hospitalist Group, Salt Lake City, UT 84143 Phone: 801-408-5482 Fax: 801-408-5481 | |
Dr. Roxanne J Weiss, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Dr. Erin L. Gosekamp, DO, MPH, MS Hospitalist Medicare: Medicare Enrolled Practice Location: 295 S Chipeta Way, Salt Lake City, UT 84108 Phone: 801-587-7572 | |
Rebecca Greaves Kim, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Mr. Vijaykumar Lingegowda, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 East 3900 S, Suite 4b, Salt Lake City, UT 84124 Phone: 866-500-7071 Fax: 866-500-7081 | |
Craig R. Goodall, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606 | |
Dr. Prathima Ramaprasad, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 E 3900 S, South Salt Lake City, Salt Lake City, UT 84124 Phone: 801-809-0641 |